Takeda Pharmaceutical Co., Ltd. (TAK)
18.60
+0.34
(+1.86%)
USD |
NYSE |
Sep 14, 16:00
18.61
+0.01
(+0.05%)
After-Hours: 20:00
Takeda Pharmaceutical Price to Book Value : 1.264 for Sept. 14, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 14, 2026 | 1.264 |
| September 11, 2026 | 1.241 |
| September 10, 2026 | 1.231 |
| September 09, 2026 | 1.238 |
| September 08, 2026 | 1.245 |
| September 04, 2026 | 1.254 |
| September 03, 2026 | 1.272 |
| September 02, 2026 | 1.253 |
| September 01, 2026 | 1.239 |
| August 31, 2026 | 1.222 |
| August 28, 2026 | 1.225 |
| August 27, 2026 | 1.225 |
| August 26, 2026 | 1.239 |
| August 25, 2026 | 1.247 |
| August 24, 2026 | 1.240 |
| August 21, 2026 | 1.236 |
| August 20, 2026 | 1.232 |
| August 19, 2026 | 1.246 |
| August 18, 2026 | 1.227 |
| August 17, 2026 | 1.181 |
| August 14, 2026 | 1.198 |
| August 13, 2026 | 1.182 |
| August 12, 2026 | 1.183 |
| August 11, 2026 | 1.188 |
| August 10, 2026 | 1.193 |
| Date | Value |
|---|---|
| August 07, 2026 | 1.186 |
| August 06, 2026 | 1.157 |
| August 05, 2026 | 1.136 |
| August 04, 2026 | 1.126 |
| August 03, 2026 | 1.144 |
| July 31, 2026 | 1.162 |
| July 30, 2026 | 1.172 |
| July 29, 2026 | 1.206 |
| July 28, 2026 | 1.191 |
| July 27, 2026 | 1.185 |
| July 24, 2026 | 1.172 |
| July 23, 2026 | 1.143 |
| July 22, 2026 | 1.147 |
| July 21, 2026 | 1.171 |
| July 20, 2026 | 1.159 |
| July 17, 2026 | 1.166 |
| July 16, 2026 | 1.137 |
| July 15, 2026 | 1.118 |
| July 14, 2026 | 1.114 |
| July 13, 2026 | 1.121 |
| July 10, 2026 | 1.126 |
| July 09, 2026 | 1.129 |
| July 08, 2026 | 1.138 |
| July 07, 2026 | 1.153 |
| July 06, 2026 | 1.148 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Sanofi | 1.460 |
| Daiichi Sankyo Co., Ltd. | 3.197 |
| Ono Pharmaceutical Co., Ltd. | 1.325 |
| Astellas Pharma, Inc. | 2.228 |
| Eisai Co., Ltd. | 1.552 |
Price to Book Value Related Metrics
| PS Ratio | 1.979 |
| Price to Free Cash Flow | 22.04 |
| Price | 18.60 |
| Earnings Yield | -1.81% |
| Market Cap | 58.79B |
| Operating PE Ratio | 12.96 |